Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 99 publications
Functionally heterogeneous intratumoral CD4+CD8+ double-positive T cells can give rise to single-positive T cells.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: January 20, 2026
Interpretation of the "Guidelines for public health adaptation actions to climate change"
Journal: Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]
Published: October 23, 2025
Renal cell carcinoma incidence and mortality in California: a population-based study of sociodemographic patterns and temporal trends from 1988 through 2019.
Journal: Lancet regional health. Americas
Published: September 19, 2025
Is it time to reconsider the role of upfront cytoreductive nephrectomy in metastatic renal cell carcinoma?
Journal: Journal of the National Cancer Institute
Published: April 26, 2024
Adjuvant Everolimus in Patients with Completely Resected, Very High-risk Renal Cell Carcinoma of Clear Cell Histology: Results from the Phase 3 Placebo-controlled SWOG S0931 (EVEREST) Trial.
Journal: European urology
Published: January 16, 2024
Bladder cancer variants share aggressive features including a CA125+ cell state and targetable TM4SF1 expression.
Journal: Nature communications
Published: October 17, 2023
Initial Experience with 68Ga-FAP-2286 PET Imaging in Patients with Urothelial Cancer.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: August 24, 2023
Wake-Up Call to Address Sleep Health in Non-Muscle Invasive Bladder Cancer: Underappreciated Contributor to Poor Quality of Life.
Journal: Bladder cancer (Amsterdam, Netherlands)
Published: August 08, 2023
Impact of Squamous Histology on Clinical Outcomes and Molecular Profiling in Metastatic Urothelial Carcinoma Patients Treated With Immune Checkpoint Inhibitors or Enfortumab Vedotin.
Journal: Clinical genitourinary cancer
Published: March 18, 2023
Complete Remission of BCG-Refractory High-grade Bladder CIS with Pharmacologic Ascorbate and Mistletoe.
Journal: Alternative therapies in health and medicine
Published: March 18, 2023
Last Updated: 09/26/2026